MNK
(NYSE)
4.53
-0.3548  (-7.83%)
Volume (24h): 10.37M Day Range: 4.43 - 5.17
Market Cap: 386.80M 52W Range: 1.43 - 27.33
Feb-14-20 12:38PM Mallinckrodt to Report Earnings Results for Fourth Quarter and Fiscal 2019PR Newswire
Feb-10-20 07:43PM New York Opioid Case A Significant Risk For Pharma Stocks, Says Bearish BofABenzinga
Feb-06-20 08:34PM 4 Stocks Looking Higher During Earnings SeasonBenzinga
05:10PM Will Mallinckrodt (MNK) Beat Estimates Again in Its Next Earnings Report?Zacks
Feb-06-20 04:17PM Four stocks to watch this week include Clovis Oncology and 3D SystemsMarketWatch
01:40PM Implied Volatility Surging for Mallinckrodt (MNK) Stock OptionsZacks
Jan-22-20 07:48PM This local regenerative medicine company is plotting its IPOAmerican City Business Journals
Jan-20-20 02:30PM Should Value Investors Consider Mallinckrodt (MNK) Stock?Zacks
01:17PM J&J's $8B Jury Award in Risperdal Case Cut to $6.8M by JudgeZacks
Jan-15-20 06:55PM Mallinckrodt's stocks soars on heavy volume toward near-40% gain this week after comments at broker conferenceMarketWatch
Jan-13-20 02:11PM Endo Up on Opioid Abuse Settlement Agreement With OklahomaZacks
Dec-30-19 02:12PM Will J&J be Able to Overcome Its Legal Troubles in 2020?Zacks
Dec-23-19 11:45AM Mallinckrodt to Present at the 38th Annual J.P. Morgan Healthcare ConferencePR Newswire
Dec-19-19 11:00AM These Are the Trades That Gutted Bonuses This YearBloomberg
Dec-17-19 03:25PM Mallinckrodt Initiates Phase IV Study on Acthar for KeratitisZacks
Dec-16-19 09:45PM First Patient Enrolled in Mallinckrodt Phase 4 Trial of Acthar® Gel (Repository Corticotropin Injection) for Severe KeratitisPR Newswire
Dec-11-19 01:52PM Implied Volatility Surging for Mallinckrodt (MNK) Stock OptionsZacks
Dec-10-19 05:49PM A Word of Caution for 2 Underperforming StocksGuruFocus.com
11:45AM Mallinckrodt Announces Plans to Update Its Incentive Compensation Clawback Policy and Create Opioid ReportPR Newswire
Dec-09-19 03:04PM Mallinckrodt International Finance SA -- Moody's downgrades Mallinckrodt's CFR to Caa2; considers transaction a distressed exchangeMoody's
Dec-07-19 05:05PM Mallinckrodt Presents Data on a Novel Predictive Model to Identify Infants at Risk for Infantile Spasms (IS) at the 2019 Annual Meeting of the American Epilepsy Society (AES)PR Newswire
Dec-06-19 04:33PM Two St. Louis companies make list of 15 worst corporate dealsAmerican City Business Journals
Dec-05-19 04:31PM Mallinckrodt (MNK) Up 28.5% Since Last Earnings Report: Can It Continue?Zacks
11:45AM Mallinckrodt plc Announces Final Results of Exchange TransactionsPR Newswire
Dec-04-19 12:59PM J&J's (JNJ) New Tests Reveal No Asbestos in Baby PowdersZacks
Dec-03-19 12:20AM Mallinckrodt Moves Date and Time of Its Fireside Chat at Piper Jaffray Annual Healthcare ConferencePR Newswire
Nov-27-19 05:36PM Possible criminal probe undermines recovery in opioid stocks since global legal settlement announcedMarketWatch
02:37PM Opioid Stocks Fall on News of Federal Criminal InvestigationBarrons.com
Nov-27-19 01:42PM Benzinga Pro's Stocks To Watch For Wednesday, Nov. 27th, 2019: DE, ADSK, GES, MNK, AMZNBenzinga
12:00PM Fed Reportedly Opens Criminal Investigation on Opioid MakersZacks
Nov-27-19 11:14AM Pharma Companies Shares Tank As Feds Investigate Opioid CrisisBenzinga
Nov-26-19 06:21PM Shares of opioid makers and distributors drop on criminal probeMarketWatch
12:08PM Shares of generic drugmakers rise on hope that legal issues are nearing an endMarketWatch
Nov-26-19 11:45AM Data on Acthar® Gel (Repository Corticotropin Injection) Therapy in Symptomatic Sarcoidosis Published in Therapeutic Advances in Respiratory DiseasePR Newswire
Nov-25-19 08:09PM Shares of generic drugmakers rise on hope that legal issues are nearing an endMarketWatch
05:49PM Shares of generic drugmakers jump in morning tradingMarketWatch
Nov-25-19 05:39PM Arnold Schneider Trims Positions in Chesapeake, CitigroupGuruFocus.com
Nov-21-19 08:20PM Endo's (ENDP) BLA for Cellulite Treatment Accepted by FDAZacks
12:00PM Market Morning: GM Sues Fiat, Pharma Fights for Pricing Privacy, More Opioid Lawsuits, Trade Deal TroublesMarket Exclusive
Nov-21-19 07:40AM Edited Transcript of MNK earnings conference call or presentation 5-Nov-19 1:30pm GMTThomson Reuters StreetEvents
02:53AM Edited Transcript of MNK earnings conference call or presentation 5-Nov-19 1:30pm GMTThomson Reuters StreetEvents
Nov-20-19 01:38AM Mallinckrodt plc Announces Early Results of Exchange TransactionsPR Newswire
Nov-19-19 11:45AM Mallinckrodt to Present at Piper Jaffray Annual Healthcare ConferencePR Newswire
03:18AM Value Investor Bill Miller’s New Stock PicksInsider Monkey
Nov-13-19 12:10PM The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips HigherBenzinga
08:39AM Edited Transcript of MNK earnings conference call or presentation 5-Nov-19 1:30pm GMTThomson Reuters StreetEvents
Nov-13-19 03:34AM Edited Transcript of MNK earnings conference call or presentation 5-Nov-19 1:30pm GMTThomson Reuters StreetEvents
Nov-12-19 09:30PM Mallinckrodt Announces New Clinical Data Evaluating Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual MeetingPR Newswire
Nov-11-19 08:30PM Mallinckrodt Presents Positive Phase 3 Results from its CONFIRM Study of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (HRS-1) at The Liver Meeting® 2019PR Newswire
Nov-08-19 11:45AM Mallinckrodt to Present at Jefferies London Healthcare ConferencePR Newswire
Mallinckrodt public limited company develops, manufactures, markets, and distributes branded pharmaceutical products in Canada and the European Union, as well as in Latin American, the Middle Eastern, African, and the Asia-Pacific regions. The company markets branded pharmaceutical products for autoimmune and rare diseases in the specialty areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies, as well as analgesics and gastrointestinal products. It offers H.P. Acthar Gel, an injectable drug for various indications, such as proteinuria, multiple sclerosis, infantile spasms, ophthalmic, neuromuscular disorders, dermatomyositis, polymyositis, rheumatology, and pulmonology; Inomax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Ofirmev, an intravenous formulation of acetaminophen for pain management; Therakos, an immunotherapy treatment platform; and Amitiza for the treatment of chronic idiopathic constipation. The company is also developing StrataGraft, which is in Phase III and II clinical development for the treatment of burns; terlipressin for the treatment of hepatorenal syndrome; MNK-1411 for the treatment of Duchenne muscular dystrophy; Stannsoporfin, a heme oxygenase inhibitor for the treatment of jaundice; Xenon gas for inhalation; MNK-6105, an ammonia scavenger for the treatment of hepatic encephalopathy, a neuropsychiatric syndrome associated with hyperammonemia; VTS-270 that is in Phase III development for Niemann-Pick Type C, a neurodegenerative fatal disease; and CPP-1X/sulindac, which is in Phase III development for Familial Adenomatous Polyposis. Mallinckrodt public limited company markets its branded products to physicians, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. The company is based in Staines-Upon-Thames, the United Kingdom.
Stocks in other countries: United Kingdom India Canada Australia
Market Cap
Volume (24h)